Trauma, shock, and disseminated intravascular coagulation: Lessons from the classical literature

Annals of Surgery

Volumn 254, Issue 1, 2011, Pages 10-19

  Gando, Satoshi ^a   Sawamura, Atsushi ^a   Hayakawa, Mineji ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN; BLOOD CLOTTING FACTOR; DEPLETED COAGULATION FACTOR; FIBRINOGEN; FIBRINOPEPTIDE A; FRESH FROZEN PLASMA; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PADGEM PROTEIN; PLASMA SUBSTITUTE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; PROTEINASE ACTIVATED RECEPTOR 1; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBIN; THROMBOCYTE CONCENTRATE; TISSUE PLASMINOGEN ACTIVATOR; TOLL LIKE RECEPTOR 4; TRANEXAMIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACIDOSIS; ARTICLE; BLEEDING; BLOOD CLOTTING; CYTOKINE RELEASE; DEATH; DIAGNOSTIC PROCEDURE; DISSEMINATED INTRAVASCULAR CLOTTING; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; FIBRINOLYSIS; HEMODILUTION; HEMORRHAGIC SHOCK; HEMOSTASIS; HUMAN; HYPOTHERMIA; HYPOXEMIA; INFLAMMATION; INJURY; INNATE IMMUNITY; ISCHEMIA; NOBLE COLLIP DRUM SHOCK; PARTIAL THROMBOPLASTIN TIME; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK REDUCTION; SHOCK; SURGICAL TECHNIQUE; THROMBOCYTE; TRAUMATIC COAGULOPATHY; TRAUMATIC SHOCK; TREATMENT CONTRAINDICATION; WOUND HEALING;

BLOOD COAGULATION; DISSEMINATED INTRAVASCULAR COAGULATION; HUMANS; SHOCK; WOUNDS AND INJURIES;

EID: 79959533830     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31821221b1     Document Type: Article

References (114)

1. Bouillon B, Brohi K, Hess JR, et al. Educational initiative on critical bleeding in Trauma: Chicago, July 11-13, 2008. J Trauma. 2010;68:225-230.
2. Hess JR, Brohi K, Dutton RP, et al. The coagulopathy of trauma: a review of mechanisms. J Trauma. 2008;65:748-754.
3. Gando S. Acute coagulopathy of trauma shock and coagulopathy of trauma: a rebuttal. You are going down the wrong path. J Trauma. 2009;67:381-383.
4. Levi M, ten Cate H, Van Der Poll T, et al. Pathogenesis of disseminated intravascular coagulation. JAMA. 1993;270:975-979.
5. Adrie C, Laurent I, Monchi M, et al. Postresuscitation disease after cardiac arrest: a sepsis-like syndrome? Curr Opin Crit Care. 2004;10:208-212. (Pubitemid 40104437)
6. Gando S. Disseminated intravascular coagulation in trauma patients. Semin Thromb Haemost. 2001;27:585-591.
7. Murray DJ, Olson J, Strauss R, et al. Coagulation changes during packed red blood cell replacement of major blood loss. Anesthesiology. 1988;69:839-845. (Pubitemid 19021628)
8. McKay DG. Trauma and disseminated intravascular coagulation. J Trauma. 1969;9:646-660.
9. Bergentz SE, Leandoer L. Disseminated intravascular coagulation in shock. Ann Chiar Gynecol Fernn. 1971;60:175-179.
10. Blombäck M, Eklund J, Hellgren M, et al. Blood coagulation and fibri-nolytic factors as well as their inhibitors in trauma. Scand J Clin Lab Invest. 1985;45(Suppl. 178):15-23. (Pubitemid 16223727)
11. Ordog GJ, Wasserberger J, Balasubramanium S. Coagulation abnormalities in traumatic shock. Ann Emerg Med. 1985;14:650-655. (Pubitemid 15071772)
12. Gando S, Tsujinaga H, Takechi S, et al. Blood coagulation and fibrinolysis in trauma patients with special reference to FPA and FPBbeta15-42. Jp J Acute Med. 1987;11:221-228.
13. Gando S, Tedo I, Kubota M. Posttrauma coagulation and fibrinolysis. Crit Care Med. 1992;20:594-600.
14. Engelman DT, Gabram SGA, Allen L, et al. Hypercoagulability following multiple trauma. World J Surg. 1996;20:5-10. (Pubitemid 26006189)
15. Guay J, Ozier Y, de Moerloose P, et al. Polytrauma and hemostatic abnormalities. Can J Anesth. 1998;45:683-691.
16. Ordog GJ, Wasserbergaer J. Coagulation abnormalities in traumatic shock. Crit Care Med. 1986;14:519.
17. Hewson JR, Neame PB, Kumar N, et al. Coagulopathy related to dilution and hypotension during massive transfusion. Crit Care Med. 1985;13:387-391. (Pubitemid 15099305)
18. Kobayashi N, Maekawa T, Takeda M, et al. Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan. Bibl Haematol. 1987;49: 848-852.
19. Japanese Ministry of Health, Labor and Welfare. The guidelines for transfusion therapy and proper use for blood products. 2005;49-55.
20. Ledgerwood AM, Lucas CE.A reviewofstudies onthe effects of hemorrhagic shock and resuscitation on the coagulation profile. J Trauma. 2003;54: S68-S74. (Pubitemid 36758854)
21. Hiippala S. Replacement of massive blood loss. Vox Sang. 1998;74(Suppl. 2):399-407. (Pubitemid 28379812)
22. Hardy JF, de Moerloose P, Samama CM. The coagulopathy of massive transfusion. Vox Sang. 2005;89:123-127. (Pubitemid 41337049)
23. Ho AMH, Karmaker MK, Dion PW. Are we giving enough coagulation factors during major trauma resuscitation? Am J Surg. 2005;190: 479-484. (Pubitemid 41139307)
24. Ketchum L, Hess JR, Hiipalla S. Indications for early fresh frozen plasma, cryoprecipitate, and platelet transfusion in Trauma. J Trauma. 2006;60: S51-S58.
25. Brohi K, Singh J, Heron M, et al. Acute traumatic coagulopathy. J Trauma. 2003;54:1127-1130. (Pubitemid 36764882)
26. MackLeod JBA, Lynn M, Mckenney MG, et al. Early coagulopathy predicts mortality in trauma. J Trauma. 2003;55:39-44. (Pubitemid 36919234)
27. Maegele M, Lefering R, Yucel N, et al. Early coagulopathy in multiple injury: an analysis from the German trauma registry on 8724 patients. Injury. 2007;38:298-304. (Pubitemid 46328919)
28. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference committee. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definition for sepsis and organ failure and guidelines for the use innovative therapies in sepsis. Crit Care Med. 1992;20:864-874.
29. Castellheim A, Brekke OL, Espevik T, et al. Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis. Scand J Immunol. 2009;69:479-491.
30. Mollen KP, Anand RJ, Tsung A, et al. Emerging paradigm: toll-like receptor 4-sentinel for the detection of tissue damage. Shock. 2006;26:430-437. (Pubitemid 44632271)
31. Bettinger DA, Pellicance JV, Tarry WC, et al. The role of inflammatory cytokines in wound healing: accelerated healing in endotoxin-resistant mice. J Trauma. 1994;36:810-813.
32. John N, Garrel DR, Bernier J. Increased burn-induced immunosuppression in lipopolysaccharide-resistant mice. Cell Immunol. 2000;200:65-75. (Pubitemid 30228255)
33. Glaros T, Larsen M, Li L. Macrophages and fibroblasts during inflammation, tissue damage and organ injury. Front Biosci. 2009;14:3988-3993.
34. Nuytinick HKS, Offermans XJMW, Kubat K, et al. Whole-body inflammation in trauma patients. Arch Surg. 1988;123:1519-1524.
35. Goris RJA. Pathophysiology of shock in trauma. Eur J Surg. 2000;166: 100-111. (Pubitemid 30096865)
36. Lenz A, Franklin GA, Cheadle WG. Systemic inflammation after trauma. Injury. 2007;38:1336-1345. (Pubitemid 350192404)
37. Esmon CT. Inflammation and thrombosis. J Thromb Haemost. 2003;1: 1343-1348.
38. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med. 1995;332:1351-1362.
39. Harris BH, Gelfand JA. The immune response to trauma. Semin Pediatric Surg. 1995;4:77-82.
40. Range-Frausto MS, Pittet D, Costigan M, et al. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA. 1995;273:117-123.
41. Hoffman M, Monroe III DM. A cell-based model of hemostasis. Thromb Haemost. 2001;85:958-965. (Pubitemid 32573743)
42. Boffard KD, Riou B, Warren B, et al. Recombinant Factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma. 2005;59:8-18. (Pubitemid 41271632)
43. Nishijima DK, Zehtabchi S. The efficacy of recombinant activated Factor VII in severe trauma. Ann Emerg Med. 2009;54:737-744.
44. Thomas GOR, Dutton RP, Hemlock B, et al. Thromboembolic complications associated with Factor VIIa administration. J Trauma. 2007;62:564-569. (Pubitemid 46568851)
45. O'Connell KA, Wood JJ, Wise RP, et al. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA. 2006;295: 293-298. (Pubitemid 43112957)
46. Nast-Kolb D, Waydhas C, Gippner-Steppert C, et al. Indicators of the post-traumatic inflammatory response correlate with organ failure in patients with multiple injuries. J Trauma. 1997;42:446-455. (Pubitemid 27155347)
47. Drake TA, Morrisey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Am J Pathol. 1989;134:1087-1097.
48. Bevilacqua MP, Pober JS, Majeau GR, et al. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med. 1984;160:618-623. (Pubitemid 14052522)
49. Bevilacqua MP, Pober JS, Majeau GR, et al. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci USA. 1986;83:4533-4537. (Pubitemid 16057083)
50. Cybulsky MI, Chan MKW, Movat HZ. Acute inflammation and microthrom-bosis induce by endotoxin, interleukin-1, and tumor necrosis factor and their implications in gram-negative infection. Lab Invest. 1988;58:365-378.
51. Armstead VE, Minchenko AG, Campbell B, et al. P-selectin is up-regulated in vital organs during murine traumatic shock. FASEB J. 1997;11:1271-1279. (Pubitemid 27527890)
52. Celi A, Pellegrini G, Lorenzet R, et al. P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci USA. 1994;91:8267-8771.
53. Armstead VE, Opentanova IL, Minchenko AG, et al. Tissue factor expression in vital organs during murine traumatic shock. Anesthesiology. 1999;91: 1844-1852.
54. Wang P, Zheng FBA, Chaudry IH. Endothelial cell dysfunction occurs very early following trauma-hemorrhage and persists despite fluid resuscitation. Am J Physiol. 1993;265:H973-H979. (Pubitemid 23296604)
55. Scalia R, Peariman S, Cambell B, et al. Time course of endothelial dysfunction and neutrophil adherence and infiltration during murine traumatic shock. Shock. 1996;6:177-182. (Pubitemid 126727758)
56. Schinkel C, Faist E, Zimmer S, et al. Kinetics of circulating adhesion molecules and chemokines after mechanical trauma and burns. Eur J Surg. 1996;162:763-768.
57. Gando S, Kameue T, Matusda N, et al. Combined activation of coagualation and inflammation has an important role in multiple organ dysfunction and poor outcome after severe trauma. Thromb Haemost. 2002;88:943-949. (Pubitemid 36018780)
58. Utter GH, Owings JT, Jacoby RC, et al. Injury induces increased monocyte expression of tissue factor: factors associated with head injury attenuate the injury-related monocyte expression of tissue factor. J Trauma. 2002;52: 1071-1077. (Pubitemid 34664376)
59. Ishii H, Majerus PW. Thrombomodulin is present in human plasma and urine. J Clin Invest. 1985;76:2178-2181. (Pubitemid 16155511)
60. Gando S, Kameue T, Nanzaki S, et al. Participation of tissue factor and thrombin in posttraumatic systemic inflammatory syndrome. Crit Care Med. 1997;25:1820-1826. (Pubitemid 27483961)
61. Dunbar NM, Chandler WL. Thrombin generation in trauma patients. Transfusion. 2009;49:2652-2660.
62. Gando S, Nanzaki S, Sasaki S, et al. Significant correlations between tissue factor and thrombin markers in trauma and septic patients with disseminated intravascular coagulation. Thromb Haemost. 1998;79:1111-1115. (Pubitemid 28297156)
63. Kannemeier C, Shibamiya A, Nakazawa F, et al. Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation. PNAS. 2007;104: 6388-6393. (Pubitemid 47186104)
64. Kahn ML, Nakanishi-Matsui M, Shapiro MJ, et al. Protease-activated receptor 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest. 1999;103:879-887. (Pubitemid 29152634)
65. Adam F, Verbeuren TJ, Fauchére JL, et al. Thrombin-induced platelet PAR4 activation: role of glycoprotein Ib and ADP. J Thromb Haemost. 2003;1: 798-804.
66. Kooistra T, Schrauwen Y, Arts J, et al. Regulation of endothelial cell t-PA synthesis and release. Int J Hematol. 1994;59:233-255. (Pubitemid 24193625)
67. O'Brodovich HM, Andrew M, Gray GW, et al. Hypoxia alters blood coagulation during acute decompression in humans. J Appl Physiol. 1984;56: 666-670. (Pubitemid 14149475)
68. Bärtsch P, Haeberli A, Hauser K, et al. Fibrinogenolysis in the absence of fibrin formation in severe hypobaric hypoxia. Aviat Space Environ Med. 1988;59:428-432.
69. Schneiderman J, Adar R, Savion N. Changes in plasmatic tissue-type plasminogen activator and plasminongen activator inhibitor activity during acute arterial occlusion associated with severe ischemia. Thromb Res. 1991;62: 401-408.
70. Pinsky DJ, Naka Y, Liao H, et al. Hypoxia-induced exocytosis of endothelial cell Weibel-Palde bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation. J Clin Invest. 1996;97:493-500.
71. Arnoud T, Michiels C, Remade J. Increased PMN adherence on endothelial cells after hypoxia: involvement of PAF, CD18/CD11b, and ICAM-1. Am J Physiol. 1993;264:C1102-C1110. (Pubitemid 23158815)
72. Bylock A, Stenberg B, Risberg B. Endothelial surface structure following hypoxia and hyperoxia. Artery. 1986;13:286-306. (Pubitemid 16099726)
73. Lawson CA, Yan SD, Liao H, et al. Monocytes and tissue factor promote thrombosis in a murine model of oxygen deprivation. J Clin Invest. 1997;99:1729-1738. (Pubitemid 27163825)
74. Yan SF, Mackman N, kisiel W, et al. Hypoxia/hypoxemia-induced activation of the procoagulant pathways and the pathogenesis of ischemia-associated thrombosis. Arterioscler Thromb Vasc Biol. 1999;19:2029-2035. (Pubitemid 29422232)
75. Gertler JP, Perry L, L'Italien G, et al. Ambient oxygen tension modulates endothelial fibrinolysis. J Vasc Surg. 1993;18:939-946. (Pubitemid 24020787)
76. Gando S, Kameue T, Nanazaki S, et al. Massive fibrin formation with consecutive impairment of fibrinolysis in patients with out-of-hospital cardiac arrest. Thromb Haemost. 1997;77:278-283.
77. Gando S, Nanzaki S, Morimoto Y, et al. Tissue factor and tissue factor pathway inhibitor levels during and after cardiopulmonary resuscitation. Thromb Res. 1999;96:107-113. (Pubitemid 29502211)
78. Turpini R, Stefanini M. The nature and mechanism of the hemostatic breakdown in the course of experimental hemorrhagic shock. J Clin Invest. 1959;38:53-65.
79. Avikainen V, Eklund B. Disseiminated intravascular coagulation after inhibition of fibrinolysis with tranexamic acid (AMCA) and proteinase inhibitor trasylolo in experimental traumatic and hemorrhagic shock. Ann Chir Gynecol Fenn. 1974;63:226-234.
80. Leandoer L, Bergentz SE. Haemorrhagic shock in the dog. The formation of thromboemboli during antifibrinolytic therapy. Eur Surg Res. 1970;2: 341-347.
81. Matini WZ, Chinkes DL, Pusateri AE, et al. Acute change in fibrinogen metabolism and coagulation after hemorrhage in pigs. Am J Physiol Endcrinol Metab. 2005;289:E930-E934. (Pubitemid 41504395)
82. Matini WZ, Chinkes DL, Sondeen J, et al. Effects of hemorrhage and lactated Ringer's resuscitation on coagulation and fibrinogen metabolism in swine. Shock. 2006;26:396-401. (Pubitemid 44402026)
83. Noble RL, Collip JB. A quantitative method for the production of experimental traumatic shock without hemorrhage in unanesthetized animals. Quart J Exper Physiol. 1942;31:187-199.
84. Tanabe K, Yoshitake J. A study on coagulation and fibrinolytic dynamics in experimental traumatic shock. Masui (Jp J Anestheiol). 1981;30:826-831. (Pubitemid 12225533)
85. Kugimiya H. A pathophysiological and biochemical study on the experimental traumatic shock in rats. A relationship between coagulation/fibrinolytic system and DIC. Masui (Jp J Anesthesiol). 1982;31:75-84.
86. Hardaway RM, Dixon RS, Foster EF, et al. The effect of hemorrhagic shock on disseminated intravascular coagulation. Ann Surg. 1976;184: 43-45.
87. Hardaway RM. The significance of coagulative and thrombotic changes after hemorrhage and injury. J Clin Pathol (Roy Coll Path). 1970;4: 110-120.
88. Flute PT. Coagulation and fibrinolysis after injury. Clin Pathol (Roy Coll Path). 1970;4:102-109.
89. Brohi K, Cohen MJ, Davenport RA. Acute coagulopathy of trauma: mechanisms, identification and effect. Curr Opin Crit Care. 2007;13:680-685. (Pubitemid 350059533)
90. Brohi K, Cohen MJ, Ganter MT, et al. Acute traumatic coagulopathy: initiated by hypoperfusion. Modulated through the protein C pathway? Ann Surg. 2007;245:812-818. (Pubitemid 46684113)
91. Brohi K, Cohen MJ, Ganter MT, et al. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma. 2008;64:1211-1217. (Pubitemid 351671214)
92. Armand R, Hess JR. Treating coagulopathy in trauma patients. Transf Med Rev. 2003;17:223-231. (Pubitemid 36900330)
93. Gando S, Nanzaki S, Kemmotsu O. Disseminated intravascular coagulation and sustained systemic inflammatory response syndrome predict organ dysfunctions after trauma. Ann Surg. 1999;229:121-127. (Pubitemid 30190389)
94. Gando S, Makise H, Tedo I. Variations in wound healing factors in trauma patients. Jp J Surg. 1990;91:17-22.
95. Gando S. Serial studies of protein C in trauma patients. Jp J Thromb Haemost. 1996;7:312-318.
96. Gando S, Nakanishi Y, Tedo I. Cytokines and plasminogen activator inhibitor in posttrauma disseminated intra vascular coagulation: relationship to multiple organ dysfunction syndrome. Crit Care Med. 1995;23:1835-1842.
97. Öhlin AK, Larsson K, Hansson M. Soluble thrombomodulin activity and soluble thrombomodulin antigen in plasma. J Thromb Haemost. 2005;3:976-982. (Pubitemid 41632829)
98. Chesebro BB, Rahn P, Carles M, et al. Increase in activated protein C mediates acute traumatic coagulopathy. Shock. 2009;32:659-665.
99. Risberg B. Fibrinolysis and trauma. Eur J Surg. 1978;10:373-381. (Pubitemid 9101734)
100. Marder VJ, Feinstein DI, Colman RW, et al. Consumptive thrombohemorrhagic disorders. In: Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ, et al. eds. Hemostasis and Thrombosis. Basic Principles and Clinical Practice. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2006: 1571-1600.
101. Sawamura A, Hayakawa M, Gando S, et al. Disseminated intravascular coagulation with a fibrinolytic phenotype at an early phase of trauma predicts mortality. Thromb Res. 2009;124:608-613.
102. Maruyama I, Sakata Y, Wada H, et al. Japanese Society of Thrombosis and Hemostasis Standardization Subcommittee for DIC. Expert consensus for the treatment of disseminated intravascular coagulation. Jpn J Thromb Hemost. 2009;20:77-113.
103. Osborn TM, Tracy JK, Dunne JR, et al. Epidemiology of sepsis in patients with traumatic injury. Crit Care Med. 2004;32:2234-2240. (Pubitemid 39491802)
104. Hayakawa M, Sawamura A, Gando S, et al. Disseminated intravascular coagulation at an early phase of trauma is associated with consumption coagulopathy and excessive fibrinolysis both by plasmin and neutrophil elastase, and thereafter dependently continues to DIC at a late phase of trauma. Surgery. 2011;149:221-230.
105. Taylor FB Jr, Toh CH, Hoots WK, et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86:1327-1330.
106. Gando S, Kameue T, Sawamura A, et al. Coagulation and fibrinolytic responses to trauma-new concepts and treatments. JAMA. 2006;17:629-644.
107. Martini WZ. Coagulopathy by hypothermia and acidosis: mechanisms of thrombin generation and fibrinogen availability. J Trauma. 2009;67:202-209.
108. Wolberg AS, Meng ZH, Monroe III DM, et al. A systemic evaluation of the effect of temperature on coagulation enzyme activity and platelet function. J Trauma. 2004;56:1221-1228. (Pubitemid 38901832)
109. Levi M, Toh CH, Thachil J, et al. Guidelines for the diagnosis and management of disseminated intravascular coagulation. Br J Haematol. 2009;145:24-33.
110. Sawamura A, Hayakawa M, Gando S, et al. Application of the Japanese Association for Acute Medicine disseminated intravascular coagulation criteria for patients at an early phase of trauma. Thromb Res. 2009;124:706-710.
111. Holcomb JB, Wade CE, Michalek JE, et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg. 2008;248:97-108.
112. Spinella PC, Holcomb JB. Resuscitation and transfusion for traumatic hemorrhagic shock. Blood Rev. 2009;23:231-240.
113. Shakur H, Roberts I, Caballero J. CRASH-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant hemorrhage (CRASH-2): a randomized placebo-controlled trial. Lancet. 2010;376:23-32.
114. Plow EF, Edgington TS. An alternative pathway for fibrinolysis. I. The cleavage of fibrinogen by leukocyte protease at physiological pH. J Clin Invest. 1975;56:30-38.